Innate Pharma works on an innovative approach against cancer: monoclonal antibodies designed to stimulate anti-tumor activity of NK cells and other cells of the innate immune system.
Immuno-oncology is changing cancer treatment by harnessing the power of the body’s immune system to recognize and kill cancer cells. This approach aims at restoring immune surveillance and can lead to durable responses in some patients who have...
Innate Pharma works on an innovative approach against cancer: monoclonal antibodies designed to stimulate anti-tumor activity of NK cells and other cells of the innate immune system.
Immuno-oncology is changing cancer treatment by harnessing the power of the body’s immune system to recognize and kill cancer cells. This approach aims at restoring immune surveillance and can lead to durable responses in some patients who have failed all available conventional therapies. One of the greatest advances in immuno-oncology involves the use of checkpoint inhibitors.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.